GridView Example Code

Radius

Understanding and Targeting Cancer Stem Cells Therapeutic Implications and Challenges

Glioblastoma Stem-like Cells Approaches for Isolation and Characterization

Non-small Cell Lung Cancer Stem Progenitor Cells Are Enriched in Multiple Distinct Phenotypic Subpopulations and Exhibit Plasticity

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

Enhanced Expression of DNA Polymerase Eta

Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma

DNA Damage Repair Pathways in Cancer Stem Cells

Aldehyde Dehydrogenase 1A1—a New Mediator of Resistance to Temozolomide in Glioblastoma

ALDH Maintains the Stemness of Lung Adenoma Stem Cells by Suppressing the Notch CDK2 CCNE Pathway

Are We Missing the Target – Cancer Stem Cells and Resistence

ALDH Isozymes Downregulation Affects Cell Growth, Cell Motility and Gene Expression in Lung Cancer Cells

MAP Kinase Signalling Pathways in Cancer

Cutting the Gordian Helix — Regulating Genomic Testing

Circumventing Cancer Drug Resistance in the Era of Personalized Medicine

Health Reform and Drug Financing. Selected Topics - Health Economics and Drugs Series, No. 006_ 3. Therapeutic Efficiency in Drug Selection and Use

In Epigenetic Therapy, Less is More

The Emerging Field of Neuroepigenetics

When Metabolism and Epigenetics Converge